China Pharma Holdings (CPHI) Gross Profit Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | China Pharma Holdings | 41.34 Mn | 41.03 Mn | 83,566.00 | 196.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 309.82% |
| Dec 31, 2025 | 193.89% |
| Sep 30, 2025 | 88.52% |
| Jun 30, 2025 | 91.43% |
| Mar 31, 2025 | 53.09% |
| Dec 31, 2024 | -102.87% |
| Sep 30, 2024 | -122.84% |
| Jun 30, 2024 | -592.34% |
| Mar 31, 2024 | -263.00% |
| Dec 31, 2023 | -285.46% |
| Sep 30, 2023 | -69.28% |
| Jun 30, 2023 | 36.06% |
| Mar 31, 2023 | 204.99% |
| Dec 31, 2022 | -85.86% |
| Sep 30, 2022 | 53.52% |
| Jun 30, 2022 | -423.07% |
| Mar 31, 2022 | -162.14% |
| Dec 31, 2021 | -46.22% |
| Sep 30, 2021 | -728.01% |
| Jun 30, 2021 | -93.83% |